STOCK TITAN

Oaktree Acquisition III Life Sciences (OACCU) Stock Price, News & Analysis

OACCU NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
0 26 sessions, September 12, 2025 to July 30, 2026
Largest daily move
-3.4% close of October 27, 2025
1-year change
+3.8% adjusted closes, September 12, 2025 to July 30, 2026

Company Description

Oaktree Acquisition III Life Sciences (NASDAQ: OACCU) is classified in the shell companies industry within the Blank Checks sector.

OACCU has gained 3.7% over the past year. Shares last traded at $11.00.

For FY2025, Oaktree Acquisition III Life Sciences reported net income of $7.3M.

This page collects what Stock Titan holds for OACCU, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
-
-
Last updated:
+3.7%
Performance 1 year

Oaktree Acquisition III Life Sciences (OACCU) stock last closed at $11.00. Over the past 12 months, the stock has gained 3.7%.

See what a $1,000 investment in OACCU would be worth today

SEC Filings

Oaktree Acquisition III Life Sciences has filed 5 recent SEC filings, including 3 Form SCHEDULE 13G, 2 Form 10-Q. The most recent filing was submitted on August 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OACCU SEC filings →

Financial Highlights

operating income reached -$1.2M, and net income was $7.3M. The company generated -$422K in operating cash flow. With a current ratio of 1.19, the company maintains adequate short-term liquidity.

$7.3M
Net Income (FY2025)
-$422K
Operating Cash Flow
Revenue (FY2025)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Oaktree Acquisition III Life Sciences (OACCU) currently stands at 2.0 thousand shares, down 0.3% from the previous reporting period. Since September 2025, short interest has decreased by 73.2%. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.

Days to Cover History

Last 12 Months

Days to cover for Oaktree Acquisition III Life Sciences (OACCU) currently stands at 1000.0 days, up 4075.3% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 3550.9% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.8 to 1000.0 days.

OACCU Company Profile & Sector Positioning

Oaktree Acquisition III Life Sciences (OACCU) operates in the Shell Companies industry within the broader Blank Checks sector and is listed on the NASDAQ.

Investors comparing OACCU often look at related companies in the same sector, including Aimei Health Technology Co., Ltd (AFJKU), Aldel Financial II (ALDFU), Bayview Acquisition Corp (BAYAU), Cayson Acquisition Corp (CAPNU), and Future Vision II Acquisition Corp (FVNNU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OACCU's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Oaktree Acquisition III Life Sciences (OACCU)?

The current stock price of Oaktree Acquisition III Life Sciences (OACCU) is $10.9988 as of July 30, 2026.

What is the net income of Oaktree Acquisition III Life Sciences (OACCU)?

The FY2025 net income of Oaktree Acquisition III Life Sciences (OACCU) is $7.3M, from its most recent completed fiscal year.

What is the operating cash flow of Oaktree Acquisition III Life Sciences (OACCU)?

The operating cash flow of Oaktree Acquisition III Life Sciences (OACCU) is -$422K. Learn about cash flow.

What is the current ratio of Oaktree Acquisition III Life Sciences (OACCU)?

The current ratio of Oaktree Acquisition III Life Sciences (OACCU) is 1.19, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Oaktree Acquisition III Life Sciences (OACCU)?

The operating income of Oaktree Acquisition III Life Sciences (OACCU) is -$1.2M. Learn about operating income.